IOL CHEMICALS & PHARM. | NGL FINE CHM | IOL CHEMICALS & PHARM./ NGL FINE CHM |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 42.5 | 32.1% | View Chart |
P/BV | x | 1.6 | 7.3 | 21.2% | View Chart |
Dividend Yield | % | 1.0 | 0.1 | 1,510.1% |
IOL CHEMICALS & PHARM. NGL FINE CHM |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
NGL FINE CHM Mar-23 |
IOL CHEMICALS & PHARM./ NGL FINE CHM |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 2,569 | 20.9% | |
Low | Rs | 272 | 1,161 | 23.4% | |
Sales per share (Unadj.) | Rs | 377.6 | 450.0 | 83.9% | |
Earnings per share (Unadj.) | Rs | 23.7 | 33.2 | 71.5% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 51.4 | 61.4% | |
Dividends per share (Unadj.) | Rs | 4.00 | 1.75 | 228.6% | |
Avg Dividend yield | % | 1.0 | 0.1 | 1,054.1% | |
Book value per share (Unadj.) | Rs | 256.8 | 360.1 | 71.3% | |
Shares outstanding (eoy) | m | 58.71 | 6.18 | 950.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 4.1 | 25.8% | |
Avg P/E ratio | x | 17.1 | 56.2 | 30.4% | |
P/CF ratio (eoy) | x | 12.8 | 36.3 | 35.3% | |
Price / Book Value ratio | x | 1.6 | 5.2 | 30.4% | |
Dividend payout | % | 16.9 | 5.3 | 319.9% | |
Avg Mkt Cap | Rs m | 23,743 | 11,523 | 206.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 369 | 456.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 2,781 | 797.3% | |
Other income | Rs m | 256 | 55 | 463.1% | |
Total revenues | Rs m | 22,427 | 2,836 | 790.8% | |
Gross profit | Rs m | 2,257 | 350 | 645.6% | |
Depreciation | Rs m | 462 | 113 | 408.8% | |
Interest | Rs m | 165 | 18 | 898.0% | |
Profit before tax | Rs m | 1,887 | 274 | 689.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 69 | 721.1% | |
Profit after tax | Rs m | 1,391 | 205 | 678.9% | |
Gross profit margin | % | 10.2 | 12.6 | 81.0% | |
Effective tax rate | % | 26.2 | 25.1 | 104.6% | |
Net profit margin | % | 6.3 | 7.4 | 85.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 1,627 | 594.3% | |
Current liabilities | Rs m | 5,025 | 583 | 862.1% | |
Net working cap to sales | % | 20.9 | 37.5 | 55.8% | |
Current ratio | x | 1.9 | 2.8 | 68.9% | |
Inventory Days | Days | 43 | 65 | 66.4% | |
Debtors Days | Days | 8 | 865 | 1.0% | |
Net fixed assets | Rs m | 11,017 | 1,244 | 885.5% | |
Share capital | Rs m | 587 | 31 | 1,900.6% | |
"Free" reserves | Rs m | 14,490 | 2,195 | 660.3% | |
Net worth | Rs m | 15,077 | 2,225 | 677.5% | |
Long term debt | Rs m | 0 | 21 | 0.0% | |
Total assets | Rs m | 20,684 | 2,871 | 720.5% | |
Interest coverage | x | 12.5 | 15.9 | 78.2% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 1.1 | 1.0 | 110.7% | |
Return on assets | % | 7.5 | 7.8 | 96.7% | |
Return on equity | % | 9.2 | 9.2 | 100.2% | |
Return on capital | % | 13.6 | 13.0 | 104.7% | |
Exports to sales | % | 26.7 | 74.3 | 36.0% | |
Imports to sales | % | 0 | 9.9 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 2,066 | 287.0% | |
Imports (cif) | Rs m | NA | 276 | 0.0% | |
Fx inflow | Rs m | 5,930 | 2,095 | 283.1% | |
Fx outflow | Rs m | 6,052 | 304 | 1,988.6% | |
Net fx | Rs m | -122 | 1,790 | -6.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 353 | 346.5% | |
From Investments | Rs m | -1,200 | -270 | 444.1% | |
From Financial Activity | Rs m | -41 | -11 | 380.2% | |
Net Cashflow | Rs m | -18 | 72 | -25.6% |
Indian Promoters | % | 48.2 | 72.7 | 66.2% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.1 | 1,700.0% | |
FIIs | % | 1.4 | 0.1 | 1,400.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 27.3 | 190.1% | |
Shareholders | 130,003 | 15,041 | 864.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA ZYDUS LIFESCIENCES DR. REDDYS LAB
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | NGL FINE CHM | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.11% | -2.67% | 0.45% |
1-Month | 5.76% | 24.84% | 2.55% |
1-Year | -2.63% | 77.38% | 56.14% |
3-Year CAGR | -12.88% | 18.07% | 15.22% |
5-Year CAGR | 16.82% | 42.97% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the NGL FINE CHM share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of NGL FINE CHM the stake stands at 72.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of NGL FINE CHM.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
NGL FINE CHM paid Rs 1.8, and its dividend payout ratio stood at 5.3%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of NGL FINE CHM.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.